Comprehensive LEFt Atrial Appendage Occlusion With Rhythm Restoration

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 240 participants.

Also called NCT07523620

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 240 participants (planned count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT07523620
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Belgium, Czechia, Denmark, Germany, Ireland, Italy, Lithuania, Poland, Spain, United Kingdom (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07523620. Allocation not applicable; no masking; primary purpose treatment. Start 2026-03-31 (actual); primary completion 2027-05-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comprehensive LEFt Atrial Appendage Occlusion With Rhythm Restoration
Acronym
CLEAR
Condition
Atrial Fibrillation (AF)
Condition
Paroxysmal AF
Condition
Persistent Atrial Fibrillation
Intervention (Procedure)
PVI Ablation
Intervention (Device)
Left Atrial Appendage Occluder Implant
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct07523620
Content hash
56cf76b88a17ced47adc97d3ad550508a090435128c237d40b482d0f99a5d6e8